WX-02-33
WX-02-33 is a TOE1 inhibitor that covalently binds TOE1 and allosterically inhibits its 3′ RNA exonuclease activity. WX-02-33 promotes the binding of TOE1 to spliceosome-associated protein complexes involved in pre-mRNA splicing in a site-specific and stereoselective manner. WX-02-33 exhibits good proteome selectivity in cancer cells, binding only TOE1_C80 and a few other cysteines. WX-02-33 can be used for research on Merkel cell carcinoma.
For research use only. We do not sell to patients.
- CAS No.: 3020765-74-3
- Formula: C26H25N3O5
- Molecular Weight:459.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
In Vitro
WX-02-33 (20 μM; 6 h) inhibits deadenylation of WT-TOE1 but not the C80S-TOE1 mutant in immunoprecipitates derived from MCC142[1].
WX-02-33 (20 μM; 6 h) promotes the binding of TOE1 to spliceosome-related complexes in MCC142 cells[1].
WX-02-33 confers a greater advantage on C80S-TOE1 than on WT-TOE1 in the mixed MCC142 competition assay[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3020765-74-3
-
Molecular Weight 459.49
-
Formula C26H25N3O5
-
SMILES
C=CC(N1[C@H](C2=CC=C(OCO3)C3=C2)C4=C(C[C@@H]1C(N5CCOCC5)=O)C6=CC=CC=C6N4)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)